Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 89778-27-8 | Product Number: T2832
Toremifene Citrate
Purity: >98.0%(T)(HPLC)
- (Z)-4-Chloro-1-(4-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate
- (Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine Citrate
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | T2832 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__6H__2__8ClNO·C__6H__8O__7 = 598.09 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 89778-27-8 |
Related CAS RN
|
89778-26-7 |
| Reaxys Registry Number | 8181005 |
| PubChem Substance ID | 160871014 |
| Merck Index (14) | 9550 |
| MDL Number | MFCD01729016 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| NMR | confirm to structure |
| Melting Point | 162 °C(dec.) |
| Solubility (soluble in) | Methanol |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P263 : Avoid contact during pregnancy and while nursing. P260 : Do not breathe dust. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. |
| HS Number | 2922190090 |
Reference
- Repurposing Toremifene for Treatment of Oral Bacterial Infections
References
- Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model
- Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth
- Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus
- Pharmacokinetics of selective estrogen receptor modulators (a review)
- Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance (a review)
References
- Silica xerogel as an implantable carrier for controlled drug delivery-evaluation of drug distribution and tissue effects after implantation
- Silica xerogel carrier material for controlled release of toremifene citrate
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.